Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022212531 - PYRIDOPYRIMIDINONE COMPOUNDS

Publication Number WO/2022/212531
Publication Date 06.10.2022
International Application No. PCT/US2022/022582
International Filing Date 30.03.2022
IPC
A61K 31/519 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 453/02 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
453Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
02containing not further condensed quinuclidine ring systems
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 471/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
C07D 519/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
519Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applicants
  • ACERAND THERAPEUTICS (USA) LIMITED [US]/[US]
Inventors
  • YU, Kuo-Long
  • GAO, Cen
  • LIU, Bin
  • KUMAR, Sanjeev
Agents
  • ZHANG, Martin
Priority Data
63/168,40831.03.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PYRIDOPYRIMIDINONE COMPOUNDS
(FR) COMPOSÉS DE PYRIDOPYRIMIDINONE
Abstract
(EN) Disclosed are compounds of formula (I): (I). Variables R1-R4, R4a, A, U, V, X, and Y and ring W are defined herein. Also disclosed are a pharmaceutical composition containing such a compound and methods of using the compound for treating cancer and inhibiting SOS1.
(FR) L'invention concerne des composés de formule (I). Les variables R1-R4, R4a, A, U, V, X et Y et le cycle W sont définis dans la description. L'invention concerne également une composition pharmaceutique contenant un tel composé et des procédés d'utilisation du composé pour le traitement du cancer et l'inhibition de SOS1.
Latest bibliographic data on file with the International Bureau